Empowering Drug Development
Avance Biosciences is a leading CRO and CTO providing CGMP and GLP-compliant assay development, assay validation, and sample testing services to support drug development and manufacturing activities for our clients world-wide.
Comprehensive Testing Solutions
Across Therapeutic Modalities
We provide comprehensive analytical solutions for various drug and biologics modalities, including gene therapies, cell therapies, vaccines, mAbs, ADCs, proteins, and small molecule drugs. These integrated services confirm product sterility, evaluate cellular responses, and quantify therapeutic antibodies and biomarkers, ensuring the safety, efficacy, and quality of pharmaceuticals for regulatory approval and patient well-being.
Comprehensive Testing Solutions Across Therapeutic Modalities
We provide comprehensive analytical solutions for various drug and biologics modalities, including gene therapies, cell therapies, vaccines, mAbs, ADCs, proteins, and small molecule drugs. These integrated services confirm product sterility, evaluate cellular responses, and quantify therapeutic antibodies and biomarkers, ensuring the safety, efficacy, and quality of pharmaceuticals for regulatory approval and patient well-being.
Analytical and Bioanalytical Services
Across Developmental Stages
We provide integrated analytical and bioanalytical testing to support drug and biologics development and manufacturing. Our multidisciplinary capabilities include genomics, cell biology, microbiology, immunoassays, analytical chemistry, and compendial assays, supporting programs from early development through commercialization.
Analytical and Bioanalytical Services Across Developmental Stages
We provide integrated analytical and bioanalytical testing to support drug and biologics development and manufacturing. Our multidisciplinary capabilities include genomics, cell biology, microbiology, immunoassays, analytical chemistry, and compendial assays, supporting programs from early development through commercialization.
State-of-art Technologies
We leverage an array of cutting-edge analytical technologies to drive their analytical and bioanalytical methods. Specializing in seamlessly integrating advanced methodologies across diverse scientific domains with CGMP and GLP regulations, our expertise spans genomics, immunoassays, cell biology, and various other sophisticated techniques.
State-of-art Technologies
We leverage an array of cutting-edge analytical technologies to drive their analytical and bioanalytical methods. Specializing in seamlessly integrating advanced methodologies across diverse scientific domains with CGMP and GLP regulations, our expertise spans genomics, immunoassays, cell biology, and various other sophisticated techniques.
Your Trusted Partner for
Analytical and Bioanalytical Solutions
Our leading scientists have designed and completed hundreds of analytical projects under CGMP/GLP regulations for the FDA, EPA, as well as European and other international regulatory agencies. This team has extensive knowledge and experience working with scientists, QA/QC professionals and project managers from over 300 pharmaceutical and biotechnology companies and organizations around the world.
Your Trusted Partner for Analytical and Bioanalytical Solutions
Our leading scientists have designed and completed hundreds of analytical projects under CGMP/GLP regulations for the FDA, EPA, as well as European and other international regulatory agencies. This team has extensive knowledge and experience working with scientists, QA/QC professionals and project managers from over 300 pharmaceutical and biotechnology companies and organizations around the world.

Cutting Edge Science
Avance Biosciences’ CGMP/GLP compliant analytical and bioanalytical methods make use of the advanced technologies including real-time PCR, ddPCR, Sanger sequencing, next-gen sequencing, ELISA, MSD, Flow Cytometry, and more.

Dedication To Quality
The Avance Biosciences team is committed to strict adherence to CGMP and GLP regulations enacted by the US, European, and other international regulatory agencies.

Extensive Experience
Our team has extensive knowledge and experience working with scientists, QA/QC professionals, and project managers from over 300 pharmaceutical and biotechnology companies and organizations throughout the world.

Open Communication
Transparency and integrity are two of our core values. Our well-trained, friendly, and professional study directors and project managers strive to complete your projects on-time with open communication channels and to your specifications.

Cutting Edge Science
Avance Biosciences’ CGMP/GLP compliant analytical and bioanalytical methods make use of the advanced technologies including real-time PCR, ddPCR, Sanger sequencing, next-gen sequencing, ELISA, MSD, Flow Cytometry, and more.

Dedication To Quality
The Avance Biosciences team is committed to strict adherence to CGMP and GLP regulations enacted by the US, European, and other international regulatory agencies.

Extensive Experience
Our team has extensive knowledge and experience working with scientists, QA/QC professionals, and project managers from over 300 pharmaceutical and biotechnology companies and organizations throughout the world.

Open Communication
Transparency and integrity are two of our core values. Our well-trained, friendly, and professional study directors and project managers strive to complete your projects on-time with open communication channels and to your specifications.
Our Quality System
Our established quality system is based on the requirements of Good Laboratory Practices, current Good Manufacturing Practices, and Quality System Regulation as promulgated by the U.S. Food and Drug Administration 21 CFR Part 58, 21 CFR Parts 210, 211, and 820 respectively, and by European and other international regulatory agencies.
Our Quality System
Our established quality system is based on the requirements of Good Laboratory Practices, current Good Manufacturing Practices, and Quality System Regulation as promulgated by the U.S. Food and Drug Administration 21 CFR Part 58, 21 CFR Parts 210, 211, and 820 respectively, and by European and other international regulatory agencies.
News & Events
Avance Biosciences will be exhibiting at Festival of Biologics USA 2026 in San Diego. Visit us at Booth #322 to learn how our CGMP-, GLP-, and CLIA-compliant bioanalytical services support biologics development, from assay development and validation to potency, immunogenicity, and advanced analytical testing[...]
When you partner with Avance Biosciences™, you gain a CRO partner that is creative, collaborative and dedicated to sound science with a focus on the regulatory requirements our partners require. Contact our technical staff to discuss how we can support you in your project!
News & Events












